The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project coordinated by the European Brain Council (EBC). According to the World Health Organization, disorders of the brain affect up to one in three people worldwide. 

A second round (VOT2) on new therapeutic areas was launched in 2019, focusing on The Value of Early Diagnosis and Coordinated Care for Rare Diseases (Ataxia, Dystonia and Phenylketonuria); and The Value of Early Intervention and Continuity of Care for Mental Disorders (Anorexia Nervosa, Autism Spectrum Disorder and Major Depressive Disorder).

Prof. Anita MacDonald will present a case study on phenylketonuria (PKU) at the 14th European Paediatric Neurology Society Congress in Glasgow, on 1 May (10:20 – 10:40).

The post Value of Treatment (VOT) case study on phenylketonuria (PKU) | EPNS Congress 2022 appeared first on European Brain Council (EBC).

The 14th European Paediatric Neurology Society Congress, to be held under the overarching theme “Precision in Child Neurology” from 28 April – 2 May 2022 in Glasgow (UK) and virtually, provides an opportunity to learn about the latest developments in the rapidly evolving field of child neurology including basic science, diagnostic methods and novel treatments. The congress theme explores how networks, systems and technology can help deliver precision care and better outcomes.

You will have the chance to learn about the EBC activities and projects in a virtual booth. In addition, EBC is pleased to hold several sessions at the congress:

• Promoting Child Neurology in Europe: 29 April 2022, 14:05 – 15:50
• Value of Treatment (VOT) case study on ataxia: 30 April, 10:20 – 10:40
• Value of Treatment (VOT) case study on phenylketonuria (PKU): 1 May 2022, 10:20 – 10:40

Register now for the 14th European Paediatric Neurology Society Congress!

The post 14th European Paediatric Neurology Society Congress appeared first on European Brain Council (EBC).